Algo version: 0.98b
HUMAW is listed at the NASDAQ Exchange
HUMAW [HUMAW]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is HUMAW stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Humacyte Inc 10 years ago, but if you had invested on Tuesday 24th of November 2020 when the price was $0.750, you would have made a profit of $0.780 per share or 104.11%

No, the average daily trading liquidity for Humacyte Inc is $77 102 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Humacyte Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Humacyte Inc to be medium [0.7 out of 1]